Evidence / Daily et al. · 2016
Review of turmeric and curcumin trials in arthritis
Selected research. Study type, product relevance and limitations are shown separately.
Editorial study summary
- Study type
- Systematic review and meta-analysis of randomized clinical trials.
- Product relevance
- Ingredient research involving turmeric extracts or curcuminoids.
- Sample or population
- Eight eligible trials, with different subsets contributing to each pooled result.
- Studied dose
- Turmeric extracts and curcumin preparations varied. The abstract describes about 1,000 mg/day of curcumin in its conclusion, rather than a common dose across all trials.
- Duration
- Varied across trials. The abstract does not report a common duration.
- Finding
- Pooled pain and WOMAC measures favoured the studied preparations in some comparisons. Pooled pain scores did not show a statistically significant difference versus pain medicines.
- Limitations
- The authors judged the number of trials, total sample and study methods insufficient for definitive conclusions. A pooled result cannot be attributed to one retail formulation.
- Study quality
- The outcomes, study design and limitations were reviewed. No formal risk-of-bias rating was assigned for this summary.
- Funding and disclosures
- The Korea Institute of Oriental Medicine funded the review. The first author disclosed that he was president of a dietary supplement manufacturer.
The studies discussed here examine ingredients or other formulations. They do not establish results for this DR.MORGAN finished product.
Licensed product information
High-Potency Turmeric Extract · NPN 80143038
Source of (an) antioxidant(s)/Provides (an) antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals.